2024, Compounding and Vaccines - Pharmacy Technician Pulse

Progress in Dermatology Paves the Way for Vaccine Development

Drug Topics

JUNE 20, 2025

With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.

Vaccines

Vaccines Independent Pharmacies Immunization Specialty Pharmacies

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

JUNE 6, 2025

Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.

Vaccines

Vaccines Immunization Compounding Specialty Pharmacies

ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust

Drug Topics

JUNE 20, 2025

Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.

Vaccines

Vaccines Immunization Specialty Pharmacies Compounding

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Drug Topics

JULY 11, 2025

In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period.

Vaccines

Vaccines Compounding Pharmacies Immunization Hospitals

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. Kennedy Jr. Industry groups have also raised serious concerns. BIO President and CEO John F.

Vaccines

Vaccines Dosage Packaging Immunization

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Drug Topics

JUNE 27, 2025

In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.

Vaccines

Vaccines Independent Pharmacies Immunization Compounding

Q&A: Supporting Pharmacy Technicians Through Daily Recognition

Drug Topics

JUNE 23, 2025

Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Health and Personal Care Stores

Health and Personal Care Stores CPhT Immunization Vaccines

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmTech

JUNE 23, 2025

Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com Performing calculations for the formulation of pharmaceutical dosage forms and related preparations is a key activity in compounding. Calculating the active moiety amount for compounding follows. Pluta Nishant B. The medication order identifies the active moiety.

Compounding

Compounding Dosage Labelling FDA

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

Drug Topics

JUNE 24, 2025

In 2024, the FDA also approved the formulation and administration of the drug, a B-lymphocyte stimulator-specific inhibiting antibody, for patients 5 years and older who have SLE. May 20, 2024. January 31, 2025. Accessed June 24, 2025. FDA approves Benlysta (belimumab) Autoinjector for children with systemic lupus erythematosus.

FDA

FDA Mayo Clinic Immunization Vaccines

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes

Drug Topics

JUNE 19, 2025

Updated November 21, 2024. Vaccine Coverage Remains Low Among Forcibly Displaced Children Brian Nowosielski June 17th 2025 Article Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.

Compounding

Compounding Vaccines Specialty Pharmacies Hospitals

Creating Space for Pharmacy Technicians to Lead and Thrive

Drug Topics

JUNE 19, 2025

Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

CPhT

CPhT Independent Pharmacies Immunization Vaccines

Pharmacists Help Patients Manage Chronic Pain

Drug Topics

JUNE 8, 2025

2024;(518):CS355235. Related Content Measles Outbreak Reaches Over 800 Confirmed Cases in the US Ashley Gallagher June 7th 2025 Article Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. Sign up today for our free Drug Topics newsletter. REFERENCES 1. adults, 2023.

Independent Pharmacies

Independent Pharmacies Community Pharmacies Compounding Vaccines

FDA Approves Sebetralstat for Hereditary Angioedema

Drug Topics

JULY 7, 2025

February 13, 2024. FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients Ashley Gallagher June 2nd 2025 Article The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors. News Release.

FDA

FDA Vaccines Specialty Pharmacies Compounding

Supporting the Well-Being of Community Pharmacy Technicians

Drug Topics

JUNE 17, 2025

Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Community Pharmacies

Community Pharmacies CPhT Immunization Vaccines

Wildfires Have Significant Impacts on Respiratory Health

Drug Topics

JUNE 9, 2025

The pollution includes fine particulate matter, ozone, nitrogen oxides, and volatile organic compounds, all of which can be transported in a smoke plume miles away from the actual fire.” These findings are from a 2024 study conducted by researchers at the University of Washington in Seattle, who followed more than 1.2 2025;74(3):40-42.

Compounding

Compounding Immunization Vaccines Specialty Pharmacies

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

JUNE 23, 2025

Successful RCM implementation can help pharmacies recover significant funds, with Outcomes reporting nearly $3 million recovered for clients in 2024 and 2025. Polek recommends pharmacies carefully select RCM partners who offer comprehensive services, quick claim reconciliation, and robust reporting capabilities.

Patient Care

Patient Care Vaccines Specialty Pharmacies Compounding

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

They have a team of highly skilled distribution professionals who can juggle efficacy and safety checks along with compounding as if they were conductors of a world-class symphony. August 8, 2024. Updated January 19, 2024. American Oncology Network. Accessed May 15, 2025. How your oncology peers manage the complexities of care.

Compounding

Compounding Compounding Pharmacies Patient Care Immunization

Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years

Drug Topics

JUNE 18, 2025

Following a switch in Sweden’s National Immunization Program (NIP), children in the country reported an increase in pneumococcal hemolytic uremic syndrome (pHUS) from 2009 through 2024. In the US, recommendations are slightly different, with PCV13 being the safest and most effective pneumococcal vaccine for both children and adults.

Immunization

Immunization Vaccines Specialty Pharmacies Compounding

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Pharmacy Times

JUNE 12, 2025

The introduction of the human papillomavirus (HPV) vaccine marked a major turning point, contributing to nearly a 50% reduction in incidence rates and a 70% decrease in mortality since the 1950s.

Vaccines

Vaccines Immunization Compounding Pharmacies FDA

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

JUNE 19, 2025

The field is expanding into autoimmune diseases, with nononcology trials representing 51% of the pipeline by late 2024. Technological advances, such as CRISPR-Cas9 and in vivo cell engineering, are addressing challenges like short-term cell persistence and antigen escape.

Compounding

Compounding Compounding Pharmacies FDA Immunization

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Pharmacy Times

JUNE 18, 2025

5,7 Based on these positive trial results, the FDA accepted lenacapavir new drug applications for priority review in early 2025, which followed a breakthrough therapy designation granted by the FDA in October 2024. Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024.

FDA

FDA Compounding Pharmacies Immunization Hospitals

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Pharmacy Times

JULY 2, 2025

Updated November 13, 2024. link] eptinezumab-jjmr -the-first-a New data demonstrates robust efficacy of Eptinezumab-jjmr® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine. News release. PR Newswire. June 21, 2025. Accessed July 2, 2025. link] Aetna. Clinical Policy Bulletin 0970: Eptinezumab‑jjmr (Eptinezumab-jjmr).

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Specialty Pharmacies

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

JUNE 4, 2025

USP labs provide unparalleled expertise in developing quality and process standards, establishing and validating analytical methods, characterizing impurities, and synthesizing organic compounds. The Advanced Technologies Lab is the latest of USP’s investments in advanced manufacturing technologies. Subscribe Now!

Compounding Pharmacies

Compounding Pharmacies Compounding Immunization Specialty Pharmacies

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Pharmacy Times

JUNE 17, 2025

National trends in prescription drug expenditures and projections for 2024. Consumer Healthcare Products Association. November 2022. Accessed May 5, 2025. link] Tichy EM, Hoffman JM, Tadrous M, et al. Am J Health Syst Pharm. 2024;81(14):583-598.

Compounding Pharmacies

Compounding Pharmacies Drug Utilization Review Immunization Hospitals

OTC Case Studies: Summer Skin Care

Pharmacy Times

JUNE 20, 2025

Updated August 9, 2024. August 28, 2024. August 28, 2024. June 21, 2024. Accessed May 12, 2025. Sunburn & your skin. Skin Cancer Foundation. Accessed May 12, 2025. Preventing mosquito bites. Accessed May 12, 2025. Preventing tick bites. Accessed May 12, 2025. About mosquito bites. Accessed May 12, 2025.

Compounding Pharmacies

Compounding Pharmacies Immunization FDA Hospitals

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Pharmacy Times

JUNE 13, 2025

CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Specialty Pharmacies

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

JUNE 24, 2025

Updated April 2, 2024. A study of JNJ-68284528, a chimeric antigen receptor T cell (CAR-T) therapy directed against B-cell maturation antigen (BCMA) in participants with relapsed or refractory multiple myeloma (CARTITUDE-1). Accessed June 24, 2025.

Compounding Pharmacies

Compounding Pharmacies Immunization Hospitals Compounding

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Pharmacy Times

JUNE 26, 2025

Gates said the idea for the program came from the Walgreens Deans Advisory Council, which Walgreens launched in 2024. Furthermore, 24.9% 2 Helping potential students navigate these challenges could encourage pharmacy school applications and benefit those who apply.

Health and Personal Care Stores

Health and Personal Care Stores Compounding Pharmacies Immunization Specialty Pharmacies

Pneumococcal Burden Remains Despite Immunization Expansion

Drug Topics

JUNE 9, 2025

Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 1 The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024.

Immunization

Immunization Vaccines Independent Pharmacies Specialty Pharmacies

STAT+: Pharmalittle: We’re reading about Lilly strategy against compounders, Bristol’s antipsychotic, and more

STAT

APRIL 23, 2025

The gambit was prompted by the penalties that companies must pay to Medicaid when they raise the price of a medicine above the inflation rate, a consequence of a provision in a federal law that went into effect in early 2024. saying it will encourage innovation , The Financial Times notes. ” The U.S. government estimates.

Compounding

Compounding Pharmaceutical Companies Pharmaceutical Companies Generic Medicine

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Pharmacy Times

JUNE 30, 2025

Last Updated November 11, 2024. Risk Evaluation and Mitigation Strategies | REMS. Last Updated May 20, 2025. Accessed June 30, 2025. American Cancer Society. CAR T-cell therapy and its side effects. Accessed June 30, 2025.

FDA

FDA Compounding Pharmacies Immunization Hospitals

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacy Times

JUNE 16, 2025

The FDA approved nemolizumab in December 2024 for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not controlled by topical prescription therapies among individuals 12 and older. May 15, 2024. December 16, 2024. June 6, 2025.

Compounding Pharmacies

Compounding Pharmacies FDA Immunization Mayo Clinic

Novo Nordisk teams up with WeightWatchers in latest telehealth push

Pharmaceutical Technology

JUNE 27, 2025

In March 2025, Novo Nordisk discounted the cost of all doses to $499 per month to competitively price its prized asset against cheaper compounded alternatives. Compounded semaglutide is a personalised weight loss medicine, which is chemically identical to branded alternatives.

Compounding

Compounding Packaging FDA Communication

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Pharmacy Times

JUNE 9, 2025

October 19, 2024. December 2024. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial. The Lancet. doi: 10.1016/S0140-6736(24)01744-6 5.

FDA

FDA Compounding Pharmacies Immunization Hospitals

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

JUNE 19, 2025

Standard-of-care treatment for patients with ALK fusions is alectinib (Alecensa; Genentech), a TKI that was approved by the FDA in 2024 for adjuvant treatment following tumor resection in patients with ALK-positive NSCLC. April 18, 2024. Updated August 9, 2024. Accessed June 19, 2025. Accessed June 19, 2025.

Chemotherapy

Chemotherapy Compounding Pharmacies Hospitals Immunization

McKesson Corporation Completes Acquisition of Core Ventures

Pharmacy Times

JUNE 3, 2025

billion, enhancing community-based oncology care and clinical development. billion, enhancing community-based oncology care and clinical development.

Specialty Pharmacies

Specialty Pharmacies CPhT Compounding Pharmacies Immunization

FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

Pharmacy Times

JUNE 23, 2025

In 2024, the FDA granted datopotamab a breakthrough therapy designation for patients with NSCLC based on data from the TROPION-Lung05 and TROPION-Lung01 trials that have since led to the agent’s accelerated approval. December 9, 2024. AstraZeneca. Accessed June 23, 2025. Pharmacy Times. June 19, 2025. Accessed June 23, 2025.

FDA

FDA Compounding Pharmacies Chemotherapy Immunization

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Pharmacy Times

JUNE 11, 2025

Records from patients who received oncology treatment from Walgreens Specialty Pharmacy from December 2023 to October 2024 were analyzed to determine the percentage of patients who opted for a fertility preservation counseling session. Materials and Methods This study design was descriptive, nonexperimental, and retrospective.

Specialty Pharmacies

Specialty Pharmacies Compounding Pharmacies Immunization Chemotherapy

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

JUNE 10, 2025

In 2024, there were an estimated 12,000 PharmD graduates and 10,466 taking the NAPLEX for the first time. July 1, 2024. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. In 2023, there were 12,639 PharmD graduates and 12,229 taking the NAPLEX for the first time. Accessed June 6, 2025.

Compounding Pharmacies

Compounding Pharmacies Hospitals Immunization Compounding

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

JUNE 17, 2025

CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.

Mail-Order Pharmacies

Mail-Order Pharmacies Compounding Pharmacies Medical Records Dosage

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Pharmacy Times

JUNE 16, 2025

CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Chemotherapy Compounding Pharmacies Immunization

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacy Times

JUNE 12, 2025

CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.

Compounding Pharmacies

Compounding Pharmacies Vaccines Immunization Specialty Pharmacies

Progress in Dermatology Paves the Way for Vaccine Development

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Trending Sources

ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust

Pneumococcal Vaccine Rates Low Despite Updated Recommendations

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

ACIP Votes Against Thimerosal Vaccines for Prevention of Influenza

Q&A: Supporting Pharmacy Technicians Through Daily Recognition

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes

Creating Space for Pharmacy Technicians to Lead and Thrive

Pharmacists Help Patients Manage Chronic Pain

FDA Approves Sebetralstat for Hereditary Angioedema

Supporting the Well-Being of Community Pharmacy Technicians

Wildfires Have Significant Impacts on Respiratory Health

Turning Reconciliation into a Revenue Growth Engine

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pneumococcal Hemolytic Uremic Syndrome Increased Among Children Over Last 15 Years

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

OTC Case Studies: Summer Skin Care

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Pneumococcal Burden Remains Despite Immunization Expansion

STAT+: Pharmalittle: We’re reading about Lilly strategy against compounders, Bristol’s antipsychotic, and more

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Novo Nordisk teams up with WeightWatchers in latest telehealth push

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

McKesson Corporation Completes Acquisition of Core Ventures

FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Stay Connected